Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle

doi:10.1016/S0024-3205(98)00584-0

Life Sciences

Volume 64, Issues 6–7, 8 January 1999, Pages 387-394

https://doi.org/10.1016/S0024-3205(98)00584-0 Get rights and content

Abstract

Muscarinic agonists elicit contraction through M₃ receptors in most isolated preparations of gastrointestinal smooth muscle, and not surprisingly, several investigators have identified M₃ receptors in smooth muscle using biochemical, immunological and molecular biological methods. However, these studies have also shown that the M₂ receptor outnumbers the M₃ by a factor of about four in most instances. In smooth muscle, M₃ receptors mediate phosphoinositide hydrolysis and Ca²⁺ mobilization, whereas M₂ receptors mediate an inhibition of cAMP accumulation. The inhibitory effect of the M₂ receptor on cAMP levels suggests an indirect role for this receptor; namely, an inhibition of the relaxant action of cAMP-stimulating agents. Such a function has been rigorously demonstrated in an experimental paradigm where gastrointestinal smooth muscle is first incubated with 4-DAMP mustard to inactivate M₂ receptors during a Treatment Phase, and subsequently, the contractile activity of muscarinic agonists is characterized during a Test Phase in the presence of histamine and a relaxant agent. When present together, histamine and the relaxant agent (e.g., isoproterenol or forskolin) have no net contractile effect because their actions oppose one another. However, under these conditions, muscarinic agonists elicit a highly potent contractile response through the M₂ receptor, presumably by inhibiting the relaxant action of isoproterenol or forskolin on histamine-induced contractions. This contractile response is pertussis toxin-sensitive, unlike the standard contractile response to muscarinic agonists, which is pertussis toxin-insensitive. When measured under standard conditions (i.e., in the absence of histamine and without 4-DAMP mustard-treatment), the contractile response to muscarinic agonists is moderately sensitive to pertussis toxin if isoproterenol or forskolin is present. Also, pertussis toxin-treatment enhances the relaxant action of isoproterenol in the field-stimulated guinea pig ileum. These results demonstrate that endogenous acetylcholine can activate M₂ receptors to inhibit the relaxant effects of β-adrenoceptor activation on M₃ receptor-mediated contractions. An operational model for the interaction between M₂ and M₃ receptors shows that competitive antagonism of the interactive response resembles an M₃ profile under most conditions, making it difficult to detect the contribution of the M₂ receptor.

References (52)

F.J. Ehlert et al.
Life Sci.
(1997)
F.J. Ehlert
Life Sci.
(1996)
F.J. Ehlert et al.
Life Sci.
(1995)
E.A. Thomas et al.
Biochem Pharmacol.
(1996)
A.F. Roffel et al.
Eur. J. Pharmacol.
(1993)
N. Watson et al.
Eur. J. Pharmacol.
(1995)
T.J. Torphy
Trends Pharmacol Sci.
(1994)
M.I. Kotlikoff et al.
Biochem. Pharmacol.
(1992)
R. Rubinstein et al.
Eur. J. Pharmacol.
(1985)
H. Kilbinger et al.
Eur. J. Pharmacol.
(1984)

T.B. Bolton et al.

Life Sci.

(1997)

R.M. Eglen et al.

Pharmacol. Rev.

(1996)

F.J. Ehlert et al.

R.M. Eglen et al.

J. Auton. Pharmacol.

(1988)

R.M. Eglen et al.

Naunyn-Schmiedeb

Arch. Pharmacol.

(1990)

Y. Kamkawa et al.

Gastroenterol

(1985)

M. Del Tacca et al.

Pharmacol.

(1990)

E.A. Thomas et al.

Mol. Pharmacol.

(1993)

L.M. Candell et al.

Mol. Pharmacol.

(1990)

E.G. Peralta et al.

Nature

(1988)

J. Lai et al.

J. Pharmacol. Exp. Ther.

(1991)

E.A. Thomas et al.

Mol. Pharmacol.

(1992)

F.J. Ehlert et al.

Life Sci.

(1998)

J. Lai et al.

J. Pharmacol. Exp. Ther.

(1992)

C.M. Yang et al.

Brit. J. Pharmacol.

(1991)

Cited by (80)

Bioengineering functional human sphincteric and non-sphincteric gastrointestinal smooth muscle constructs
2016, Methods
Citation Excerpt :
GI SMCs can be isolated from the gut, expanded and cultured in vitro, however, over time SMCs will lose their characteristic contractile phenotype and acquire a synthetic phenotype in culture [28–30]. A contractile SMC phenotype is characterized by expression of SMC markers including smoothelin, α smooth muscle actin (SMA), caldesmon and calponin along with decreased migration and proliferation of cells [29,31]. SMCs that have acquired a synthetic phenotype will down regulate SMC markers and begin to migrate and proliferate [29,32].
Digestion and motility of luminal content through the gastrointestinal (GI) tract are achieved by cooperation between distinct cell types. Much of the 3 dimensional (3D) in vitro modeling used to study the GI physiology and disease focus solely on epithelial cells and not smooth muscle cells (SMCs). SMCs of the gut function either to propel and mix luminal contents (phasic; non-sphincteric) or to act as barriers to prevent the movement of luminal materials (tonic; sphincteric). Motility disorders including pyloric stenosis and chronic intestinal pseudoobstruction (CIPO) affect sphincteric and non-sphincteric SMCs, respectively. Bioengineering offers a useful tool to develop functional GI tissue mimics that possess similar characteristics to native tissue. The objective of this study was to bioengineer 3D human pyloric sphincter and small intestinal (SI) constructs in vitro that recapitulate the contractile phenotypes of sphincteric and non-sphincteric human GI SMCs. Bioengineered 3D human pylorus and circular SI SMC constructs were developed and displayed a contractile phenotype. Constructs composed of human pylorus SMCs displayed tonic SMC characteristics, including generation of basal tone, at higher levels than SI SMC constructs which is similar to what is seen in native tissue. Both constructs contracted in response to potassium chloride (KCl) and acetylcholine (ACh) and relaxed in response to vasoactive intestinal peptide (VIP). These studies provide the first bioengineered human pylorus constructs that maintain a sphincteric phenotype. These bioengineered constructs provide appropriate models to study motility disorders of the gut or replacement tissues for various GI organs.
Flavonoid galetin 3,6-dimethyl ether attenuates Guinea pig ileum contraction through K<sup>+</sup> channel activation and decrease in cytosolic calcium concentration
2015, European Journal of Pharmacology
Citation Excerpt :
Previously, FGAL was shown to have an equipotent spasmolytic effect on guinea pig ileum contracted by CCh- and histamine (Macêdo et al., 2011). Thus, because the mechanisms involved in tonic contraction maintenance differ from those that induce phasic contraction (Abdel-Latif, 1989), we decided to determine whether this flavonoid relaxes guinea pig ileum pre-contracted by KCl, an electromechanical contractile agent, as well as by histamine and carbachol, both pharmacomechanical coupled contractile agents whose effects are mediated by histaminergic (H1) and muscarinic (M3) receptors, both coupled to the Gq/11 protein, which functions as a transducer to activate the IP3/DAG signaling pathway, leading to increased cytosolic Ca2+ levels (Ash and Schild, 1966; Berridge et al., 2003; Ehlert et al., 1999). FGAL was equipotent in relaxing the ileum pre-contracted with KCl or CCh, but showed high potency when histamine was employed as the contractile agent.
Flavonoid galetin 3,6-dimethyl ether (FGAL) has been isolated from the aerial parts of Piptadenia stipulaceae and has shown a spasmolytic effect in guinea pig ileum. Thus, we aimed to characterize its relaxant mechanism of action. FGAL exhibited a higher relaxant effect on ileum pre-contracted by histamine (EC₅₀=1.9±0.4×10⁻⁷ M) than by KCl (EC₅₀=2.6±0.5×10⁻⁶ M) or carbachol (EC₅₀=1.8±0.4×10⁻⁶ M). The flavonoid inhibited the cumulative contractions to histamine, as well as to CaCl₂ in depolarizing medium nominally Ca²⁺-free. The flavonoid relaxed the ileum pre-contracted by S-(–)-Bay K8644 (EC₅₀=9.5±1.9×10⁻⁶ M) but less potently pre-contracted by KCl or histamine. CsCl attenuated the relaxant effect of FGAL (EC₅₀=1.1±0.3×10⁻⁶ M), but apamin or tetraethylammonium (1 mM) had no effect (EC₅₀=2.6±0.2×10⁻⁷ and 1.6±0.3×10⁻⁷ M, respectively), ruling out the involvement of small and big conductance Ca²⁺-activated K⁺ channels (SK_Ca and BK_Ca, respectively). Either 4-aminopyridine or glibenclamide attenuated the relaxant effect of FGAL (EC₅₀=1.8±0.2×10⁻⁶ and 1.5±0.5×10⁻⁶ M, respectively), indicating the involvement of voltage- and ATP-sensitive K⁺ channels (K_V and K_ATP, respectively). FGAL did not alter the viability of intestinal myocytes in the MTT assay and decreased (88%) Fluo-4 fluorescence, indicating a decrease in cytosolic Ca²⁺ concentration. Therefore, the relaxant mechanism of FGAL involves pseudo-irreversible noncompetitive antagonism of histaminergic receptors, K_V and K_ATP activation and blockade of Ca_V1, thus leading to a reduction in cytosolic Ca²⁺ levels.
Inhibitory effect of sanguinarine on PKC-CPI-17 pathway mediating by muscarinic receptors in dispersed intestinal smooth muscle cells
2013, Research in Veterinary Science
Citation Excerpt :
These results demonstrate that SA mainly inhibits extracellular Ca2+ influx through the Ca2+channel, also known as receptor-operative Ca2+channel. Previous pharmacological studies have shown that m3 and m2 receptors are the two main muscarinic receptor types expressed in visceral and vascular smooth muscle (Zhang et al., 1991; Ehlert et al., 1997; Murthy and Makhlouf, 1997; Ehlert et al., 1999). RT-PCR analysis of rat cultured ISMC used in this study confirmed the mRNA expression of m2 and m3 receptors (Fig. 4).
This study investigated the inhibitory effects of sanguinarine (SA) on PKC-CPI-17 pathway in rat intestinal smooth muscle cells (ISMC). Previous studies indicate that the inhibitory effects of SA on ISMC contraction are possibly mediated by the Ca²⁺ influx. ISMC was treated with 1 μM SA for 24 h remarkably inhibited the mRNA expression of m₂ and m₃ receptors. ISMC treated with 1 or 3 μM SA for 30 min significantly decreased the mRNA expression of PKC-δ, PKC-ε, PKC-η, and CPI-17. 1 μM SA could markedly inhibit carbachol (CCh)-mediated increase PKC-δ, PKC-η, and CPI-17 mRNA but had no effect in PKC-ε.Treatment of ISMC with SA (1 μM, 30 min) caused a decrease in protein expression of PKC-δ. However, the expression of CPI-17 was significantly inhibited in a time-dependent manner. These results demonstrate that the inhibitory effect of SA is coupled with alteration of PKC-mediated signal transduction and intracellular Ca²⁺ concentration.
The effects of jatrorrhizine on contractile responses of rat ileum
2011, European Journal of Pharmacology
Citation Excerpt :
Cholinergic signaling is mediated by muscarinic acetylcholine receptors expressed in the muscle layers of gastrointestinal tract, which is involved in the regulation of excitatory action of gastrointestinal smooth muscles (Eglen et al., 1996; Murthy, 2006). Among muscarinic acetylcholine receptor subtypes in the gastrointestinal tracts, both M2 and M3 mediated the intestinal smooth muscle contraction (Ehlert et al., 1999), which is considered as the basis of functional gut movements, including peristalsis (Jin et al., 1999; Olsson and Holmgren, 2001; Prins et al., 2000). Thus, the muscarinic receptor antagonists were used to evaluate a possible involvement of muscarinic receptor pathways in jatrorrhizine-induced contraction of gastrointestinal smooth muscles in this study.
This study was designed to evaluate the effect of jatrorrhizine on smooth muscle contractions isolated from rat ileum longitudinal muscles. Jatrorrhizine increased the amplitude of spontaneous contractions of ileum longitudinal muscles in concentration-dependent manner with an EC₅₀ of 30.0 ± 8.4 μM. Preincubation of ileum strips with atropine (1 μM), 4-diphenyllacetoxy-N (2-chloriethyl)-piperidine (4-DAMP, 1 μM) or darifenacin (1 μM) significantly inhibited acetylcholine (0.1 μM)- and jatrorrhizine (100 μM)-induced ileum longitudinal muscle contractions, whereas they were not affected by AF-DX116 (1 μM) or hexamethonium (100 μM). Pretreatment with SB204070 (1 μM) rather than 3-tropanyl-indole-3-carboxyleat (tropisetron, 1 μM) significantly inhibited 5-HT (10 μM)-induced ileum longitudinal muscle contractions. In contrast, jatrorrhizine-induced ileum longitudinal muscle contractions were not inhibited by tropisetron or SB204070. Furthermore, jatrorrhizine-induced ileum longitudinal muscle contractions were strongly inhibited by nifedipine (1 μM), and also attenuated by removal of extracellular Ca²⁺, U73122 (1 μM), ruthenium red (50 μM) or 2-aminoethoxydiphenylborate (2-APB, 10 μM). Taken together, jatrorrhizine-elicited spontaneous contractions in rat ileum longitudinal muscles are mediated by activation of acetylcholine receptors, mostly the M₃ receptor. Ca²⁺ influx through L-type Ca²⁺ channel is significantly contributed to jatrorrhizine-elicited spontaneous contractions, and Ca²⁺ release via IP₃ and ryanodine pathways are also involved.
Microbiota-derived acetylcholine can promote gut motility in Drosophila melanogaster
2024, Philosophical Transactions of the Royal Society B: Biological Sciences
Effects of natural products on functional constipation: analysis of active ingredient and mechanism
2024, Naunyn-Schmiedeberg's Archives of Pharmacology

View all citing articles on Scopus

View full text

Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle

Abstract

Life Sci.

Life Sci.

Life Sci.

Biochem Pharmacol.

Eur. J. Pharmacol.

Eur. J. Pharmacol.

Trends Pharmacol Sci.

Biochem. Pharmacol.

Eur. J. Pharmacol.

Eur. J. Pharmacol.

Life Sci.

Pharmacol. Rev.

J. Auton. Pharmacol.

Naunyn-Schmiedeb

Arch. Pharmacol.

Gastroenterol

Pharmacol.

Mol. Pharmacol.

Mol. Pharmacol.

Nature

J. Pharmacol. Exp. Ther.

Mol. Pharmacol.

Life Sci.

J. Pharmacol. Exp. Ther.

Brit. J. Pharmacol.

Contractile role of M₂ and M₃ muscarinic receptors in gastrointestinal smooth muscle